Antiepileptic drug selection in pediatric epilepsy

Journal of Child Neurology

Volumn 17, Issue SUPPL. 2, 2002, Pages

  Crumrine, Patricia K ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CINROMIDE; CLOBAZAM; CLONAZEPAM; CORTICOTROPIN; DIAZEPAM; FELBAMATE; FLUNARIZINE; GABAPENTIN; IMMUNOGLOBULIN; LAMOTRIGINE; LORAZEPAM; NITRAZEPAM; PARALDEHYDE; PHENOBARBITAL; PHENYTOIN; PREDNISONE; PRIMIDONE; PROTIRELIN; PYRIDOXINE; TIAGABINE; TOPIRAMATE; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADOLESCENT; ADULT; AGE; ANTICONVULSANT THERAPY; APPETITE DISORDER; ARTICLE; BEHAVIOR DISORDER; BRAIN SURGERY; CHILD; CHILDHOOD DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG ABSORPTION; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; ENDOCRINE DISEASE; EPILEPSY; FAMILY COUNSELING; FOCAL EPILEPSY; GRAND MAL SEIZURE; HUMAN; KETOGENIC DIET; LENNOX GASTAUT SYNDROME; MEDICAL DECISION MAKING; MENSTRUAL IRREGULARITY; OVARY POLYCYSTIC DISEASE; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RASH; RECURRENCE RISK; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0036250267     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738020170020701     Document Type: Article

References (58)

1. Epilepsy after a first unprovoked seizure in childhood
2. The first unprovoked, untreated seizure in childhood: A hospital based study of the accuracy of the diagnosis, rate of recurrence, and long term outcome after recurrence. Dutch study of epilepsy in childhood
3. Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure
4. Clinical course of untreated tonic-clonic seizures in childhood: Prospective, hospital based study
5. Dosage form considerations in the treatment of pediatric epilepsy
6. Pharmacokinetic principles of antiepileptic therapy in children
7. Phenobarbital compared with phenytoin for the treatment of neonatal seizures
8. Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years
9. Characterization and classification of neonatal seizures
10. ACTH and prednisone in childhood seizure disorders
11. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: A prospective, randomized, blinded study
12. A controlled study of prednisone therapy in infantile spasms
13. A controlled study of ACTH therapy in infantile spasms
14. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis
15. Prospective study of outcome of infants with infantile spasms treated during controlled studies of ACTH and prednisone
16. Severe encephalopathic epilepsy in infants: West syndrome
17. High dose/long duration vs. low dose/short duration corticotropin therapy in infantile spasms
18. Valproic acid efficacy, toxicity, and pharmacokinetics in neonates with intractable seizures
19. Treatment of infantile spasms with high dose of ACTH: Efficacy and plasma levels of ACTH and cortisol
20. ACTH and steroids
21. Successful treatment of infants with the ketogenic diet, abstract
22. Lennox-Gastaut syndrome
23. The Group for the Evaluation of Cinromide in the Lennox-Gastaut Syndrome: Double-blind, placebo-controlled evaluation of cinromide in patients with the Lennox-Gastaut syndrome
24. Double-blind, placebo-controlled trial of flunarizine as add-on therapy in refractory childhood epilepsy
25. The Felbamate Study Group in Lennox-Gastaut Syndrome: Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome)
26. High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Gastaut syndrome; an add-on study
27. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome
28. A double-blind study of topiramate in children with Lennox-Gastaut syndrome
29. Efficacy and safety of topiramate in refractory epilepsy: A long-term prospective trial
30. LPRFSR: Topiramate in Lennox-Gastaut syndrome: Open-label treatment of patients completing a randomized controlled trial
31. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure
32. Lennox-Gastaut syndrome
33. Felbamate
34. Effects of zonisamide on children with epilepsy
35. Current topics of treatment
36. Seizures decrease rapidly after fasting. Preliminary studies of the ketogenic diet
37. Vagus nerve stimulation treatment for Lennox-Gastaut syndrome
38. Vagus nerve stimulation (VNS) in Lennox-Gastaut syndrome (LGS), abstract
39. Vagus nerve stimulation in 16 children with refractory epilepsy
40. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures
41. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults
42. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy
43. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy
44. Lamotrigine for the treatment of epilepsy in childhood
45. Treatment decisions in childhood seizures
46. Prognossis of epilepsy in newly referred patients. A multicenter prospective study of the effects of monotherapy on the long-term course of epilepsy
47. Intractable epilepsy
48. Uncontrolled epilepsy in children
49. Intractable epilepsy in a population-based series of mentally retarded children
50. Outcome of childhood epilepsy: A population-based study with a simple predictive scoring system for those treated with medication
51. Behavior disturbance, phenobarbital, and febrile seizures
52. Long-term effect of phenobarbital on cognitive function in children with febrile convulsions
53. Phenobarbital treatment and major depressive disorder in children with epilepsy
54. Adverse neuropsychiatric effects of anticonvulsant drugs
55. Aggressive behavior in intellectually challenged patients with epilepsy treated with lamotrigine
56. Factors associated with behavioral and cognitive abnormalities in children receiving topiramate
57. Childhood epilepsy and asthma: Comparison of quality of life
58. Adolescents with active or inactive epilepsy or asthma: A comparison of quality of life